Insider Sale: CHIEF ACCOUNTING OFFICER of $CRWD Sells 5 Shares

Anurag Saha, the CHIEF ACCOUNTING OFFICER of $CRWD, sold 5 shares of the company on 03-21-2025 for an estimated $1,779. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.0% of their shares of this class of stock. Following this trade, they now own 37,637 shares of this class of $CRWD stock.

$CRWD Insider Trading Activity

$CRWD insiders have traded $CRWD stock on the open market 133 times in the past 6 months. Of those trades, 0 have been purchases and 133 have been sales.

Here’s a breakdown of recent trading of $CRWD stock by insiders over the last 6 months:

• SAMEER K GANDHI has made 0 purchases and 63 sales selling 62,500 shares for an estimated $24,076,857.
• SHAWN HENRY (CHIEF SECURITY OFFICER) has made 0 purchases and 27 sales selling 46,227 shares for an estimated $16,715,754.
• GEORGE KURTZ (PRESIDENT AND CEO) has made 0 purchases and 12 sales selling 40,520 shares for an estimated $14,552,103.
• GERHARD WATZINGER has made 0 purchases and 3 sales selling 30,000 shares for an estimated $10,468,026.
• BURT W. PODBERE (CHIEF FINANCIAL OFFICER) has made 0 purchases and 9 sales selling 24,746 shares for an estimated $8,862,012.
• MICHAEL SENTONAS (PRESIDENT) has made 0 purchases and 6 sales selling 24,344 shares for an estimated $8,728,615.
• DENIS OLEARY has made 0 purchases and 4 sales selling 17,530 shares for an estimated $6,359,008.
• ANURAG SAHA (CHIEF ACCOUNTING OFFICER) has made 0 purchases and 8 sales selling 8,358 shares for an estimated $3,041,454.
• ROXANNE S AUSTIN sold 5,000 shares for an estimated $1,935,050

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CRWD Hedge Fund Activity

We have seen 939 institutional investors add shares of $CRWD stock to their portfolio, and 830 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• TWO SIGMA ADVISERS, LP removed 1,066,100 shares (-99.5%) from their portfolio in Q4 2024, for an estimated $364,776,776
• PATHSTONE HOLDINGS, LLC added 1,017,678 shares (+379.0%) to their portfolio in Q4 2024, for an estimated $348,208,704
• JPMORGAN CHASE & CO removed 960,116 shares (-26.0%) from their portfolio in Q4 2024, for an estimated $328,513,290
• STRATEGY CAPITAL LLC removed 847,784 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $290,077,773
• MORGAN STANLEY added 725,034 shares (+11.3%) to their portfolio in Q4 2024, for an estimated $248,077,633
• UBS GROUP AG added 670,299 shares (+44.4%) to their portfolio in Q4 2024, for an estimated $229,349,505
• SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 663,450 shares (-63.6%) from their portfolio in Q4 2024, for an estimated $227,006,052

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CRWD Congressional Stock Trading

Members of Congress have traded $CRWD stock 8 times in the past 6 months. Of those trades, 6 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CRWD stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 03/07.
• REPRESENTATIVE GREG LANDSMAN has traded it 3 times. They made 2 purchases worth up to $30,000 on 02/26, 02/18 and 1 sale worth up to $15,000 on 10/15.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 4 times. They made 3 purchases worth up to $45,000 on 01/28 and 1 sale worth up to $15,000 on 01/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CRWD Analyst Ratings

Wall Street analysts have issued reports on $CRWD in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 03/10/2025
• Goldman Sachs issued a "Buy" rating on 03/05/2025
• BMO Capital issued a "Outperform" rating on 03/05/2025
• Wedbush issued a "Outperform" rating on 03/05/2025
• RBC Capital issued a "Outperform" rating on 03/05/2025
• Susquehanna issued a "Positive" rating on 03/05/2025
• Wells Fargo issued a "Overweight" rating on 03/05/2025

To track analyst ratings and price targets for $CRWD, check out Quiver Quantitative's $CRWD forecast page.

$CRWD Price Targets

Multiple analysts have issued price targets for $CRWD recently. We have seen 17 analysts offer price targets for $CRWD in the last 6 months, with a median target of $415.0.

Here are some recent targets:

• An analyst from UBS set a target price of $425.0 on 03/06/2025
• An analyst from BMO Capital set a target price of $405.0 on 03/05/2025
• An analyst from D.A. Davidson set a target price of $415.0 on 03/05/2025
• An analyst from Wedbush set a target price of $395.0 on 03/05/2025
• An analyst from Raymond James set a target price of $390.0 on 03/05/2025
• An analyst from Susquehanna set a target price of $425.0 on 03/05/2025
• An analyst from Robert W. Baird set a target price of $405.0 on 03/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.